Esomeprazole + Cimetidine

Phase 3Completed
0 views this week 0 watching Active
Interest: 40/100
40
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Stress Ulcer Prophylaxis

Conditions

Stress Ulcer Prophylaxis

Trial Timeline

Jul 1, 2014 → Feb 1, 2016

About Esomeprazole + Cimetidine

Esomeprazole + Cimetidine is a phase 3 stage product being developed by AstraZeneca for Stress Ulcer Prophylaxis. The current trial status is completed. This product is registered under clinical trial identifier NCT02157376. Target conditions include Stress Ulcer Prophylaxis.

What happened to similar drugs?

8 of 20 similar drugs in Stress Ulcer Prophylaxis were approved

Approved (8) Terminated (1) Active (12)
solifenacinAstellas PharmaApproved
duloxetine HClEli LillyApproved
Minocycline + PlaceboJohnson & JohnsonApproved
Placebo + sertralineJohnson & JohnsonApproved
Adjunctive asenapineMerckApproved
ZiprasidonePfizerApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02157376Phase 3Completed

Competing Products

20 competing products in Stress Ulcer Prophylaxis

See all competitors
ProductCompanyStageHype Score
Duloxetine + placeboEli LillyPhase 2
35
agenT-797MiNK TherapeuticsPhase 1
19
Thermal stress and performance without a pre-cooling protocolPetros PharmaceuticalsPre-clinical
16
solifenacinAstellas PharmaApproved
43
SivelestatEli LillyPhase 1/2
32
Duloxetine + PlaceboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40
Duloxetine + PlaceboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40
Duloxetine hydrochlorideEli LillyPhase 3
36
DuloxetineEli LillyPhase 3
40
duloxetine + PlaceboEli LillyPhase 2
35
Exenatide + InsulinEli LillyPhase 2/3
38
DuloxetineEli LillyPhase 3
40
duloxetine HClEli LillyApproved
43
Orforglipron + PlaceboEli LillyPhase 3
47
Duloxetine hydrochloride + placeboEli LillyApproved
43
Duloxetine + PlaceboEli LillyPhase 3
40
duloxetine + placeboEli LillyPhase 3
40
DuloxetineEli LillyPhase 3
40